Literature DB >> 11160482

Primary diffuse leptomeningeal gliomatosis predominantly affecting the spinal cord: case report and review of the literature.

A Baborie1, E M Dunn, L R Bridges, J M Bamford.   

Abstract

Primary leptomeningeal gliomatosis is a rare, fatal neoplastic syndrome. A 71 year old man is reported on, who after a 2 month history of back stiffness, epigastric pain, and weight loss developed visual blurring. Cranial CT and MRI studies showed no leptomeningeal enhancement. Examination of CSF 10 weeks premortem showed an increase in protein and decrease in glucose but no malignant cells. He became increasingly confused and repeated CSF examination showed inflammation and a few suspicious cells but no definitive evidence of neoplasia. He died 7 months after onset of his initial symptoms. At postmortem meningeal whitening was seen at the base of the brain and over the spinal cord. Histology disclosed diffuse leptomeningeal gliomatosis (GFAP positive, cytokeratin negative) over the brain, optic nerves, and spinal cord without parenchymal involvement. No tumour was found in internal organs. The diagnosis of primary leptomeningeal gliomatosis was not evident after cranial CT and MRI and CSF examination premortem. Suspected cases need MRI scanning of the entire neuraxis and meningeal biopsy.

Entities:  

Mesh:

Year:  2001        PMID: 11160482      PMCID: PMC1737201          DOI: 10.1136/jnnp.70.2.256

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  9 in total

1.  Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis.

Authors:  Enrico Franceschi; Giovanna Cavallo; Luciano Scopece; Roberta Degli Esposti; Gabriele Paioli; Anna Paioli; Emanuela Palmerini; Maria Pia Foschini; Anna Federica Marliani; Lucio Crinò
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

2.  A case report and review of the literature.

Authors:  Shoji Yomo; Tsuyoshi Tada; Shuichi Hirayama; Naoko Tachibana; Masako Otani; Yuichiro Tanaka; Kazuhiro Hongo
Journal:  J Neurooncol       Date:  2006-09-20       Impact factor: 4.130

3.  A case of primary leptomeningeal gliomatosis confined to the spinal cord.

Authors:  Robin Bhatia; Federico Roncaroli; Piers Thomas; Shie-Lee Cheah; Amrish Mehta; Mark Glaser; Christian Ulbricht
Journal:  J Neurooncol       Date:  2009-11-08       Impact factor: 4.130

4.  Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide: case report and literature review.

Authors:  Niels Hansen; A Wittig; J Hense; O Kastrup; E R Gizewski; J A P Van de Nes
Journal:  Eur J Med Res       Date:  2011-09-12       Impact factor: 2.175

5.  Disseminated primary diffuse leptomeningeal gliomatosis: a case report with liquid based and conventional smear cytology.

Authors:  Masha Bilic; Cynthia T Welsh; Zoran Rumboldt; Rana S Hoda
Journal:  Cytojournal       Date:  2005-09-20       Impact factor: 2.091

6.  Primary diffuse leptomeningeal gliomatosis: An autopsy case report.

Authors:  Shaik Afshan Jabeen; Arikapadu Haritha Chowdary; Rukmini Mridula Kandadai; Megha S Uppin; Angamattu Kanikannan Meena; Rupam Borgohain; Challa Sundaram
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383

7.  Lumbosacral glioblastoma and leptomeningeal gliomatosis complicating the course of a cervicothoracic astrocytoma WHO grade II.

Authors:  Daniel Klase; Stefan Gottschalk; Erich Reusche; Christian Hagel; Einar Goebel; Volker Tronnier; Alf Giese
Journal:  Childs Nerv Syst       Date:  2007-04-14       Impact factor: 1.532

Review 8.  Diffuse leptomeningeal gliomatosis initially presenting with intraventricular hemorrhage: a case report and literature review.

Authors:  Min Zhu; JunJun Zheng; Yuanzhao Zhu; Hui Wan; Yuchen Wu; Daojun Hong
Journal:  BMC Neurol       Date:  2015-05-10       Impact factor: 2.474

9.  Primary diffuse leptomeningeal gliomatosis as a rare cause of pain in cervical spine.

Authors:  Štefan Sivák; Ema Kantorová; Egon Kurča; Juraj Marcinek; Pavol Slávik; Jozef Michalik; Vladimír Nosáľ
Journal:  BMC Cancer       Date:  2016-03-04       Impact factor: 4.430

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.